3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow VaxGen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HIV Vaccine Trial in Thai Adults ALVAC-HIV vCP1521 + AIDSVAX, ALVAC Placebo + AIDSVAX Placebo - HIV Infection | Phase 3 | Completed | U.S. Army Medical Research and Development Command | 16402 | 2003-10-01 | 2019-04-24 |
| Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand MN rgp120/HIV-1 and A244 rgp120/HIV-1 - HIV Infections, HIV Seronegativity | Phase 3 | Completed | VaxGen | 2500 | 1999-03-01 | 2005-06-24 |
| Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 - HIV Infections, HIV Seronegativity | Phase 3 | Completed | VaxGen | 5000 | 2005-06-24 |
HIV Infections (3) · Acquired Immunodeficiency Syndrome (1) · Sexually Transmitted Diseases (1) · Substance Abuse, Intravenous (1)
AIDSVAX (1)
Thailand (2) · Canada (1) · Netherlands (1) · Puerto Rico (1) · United States (1)
Kachit Choopanya (1) · Supachai Rerks-Ngarm, MD (1)
PMID 19149819, PMID 19843557, PMID 20079620, PMID 22205930, PMID 24504509, PMID 24829343, PMID 25350851, PMID 28131393, PMID 29702672, PMID 31999736, PMID 37256916, PMID 40190112